Column Capital Advisors’s CME Group CME Stock Holding History

Column Capital Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$88.9K	Sell	444 -5	-1%	-$994	0.01%	243
2023 Q2	$83.2K	Sell	449 -3	-0.7%	-$554	0.01%	247
2023 Q1	$86.6K	Hold	452	–	–	0.01%	247
2022 Q4	$76K	Buy	452 +148	+49%	+$25.7K	0.01%	241
2022 Q3	$54K	Hold	304	–	–	0.01%	261
2022 Q2	$62K	Hold	304	–	–	0.01%	243
2022 Q1	$72K	Buy	304 +273	+881%	+$64.1K	0.01%	241
2021 Q4	$7K	Sell	31 -9	-23%	-$1.98K	﹤0.01%	541
2021 Q3	$8K	Sell	40 -3	-7%	-$608	﹤0.01%	494
2021 Q2	$9K	Sell	43 -12	-22%	-$2.53K	﹤0.01%	484
2021 Q1	$11K	Hold	55	–	–	﹤0.01%	447
2020 Q4	$10K	Sell	55 -293	-84%	-$49.8K	﹤0.01%	461
2020 Q3	$58K	Buy	348 +123	+55%	+$20.7K	0.02%	227
2020 Q2	$36K	Buy	225 +38	+20%	+$6.81K	0.01%	293
2020 Q1	$32K	Buy	187 +132	+240%	+$26.3K	0.01%	256
2019 Q4	$11K	Buy	+55	New	+$11.3K	0.01%	431

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Column Capital Advisors's CME Position: Q3 2023 in Review

Column Capital Advisors reduced its CME Group (CME) stake by 1.1% in Q3 2023, selling an estimated $994 and leaving 444 shares worth $88.9K. The position accounts for 0.01% of the portfolio, ranked #243.

Column Capital Advisors first reported a position in CME in Q4 2019 and has held it in 16 quarters since. 1,230 funds tracked by Wall St. Rank hold CME as of Q3 2023.

Column Capital Advisors held 444 shares of CME Group worth $88.9K as of Q3 2023.
Column Capital Advisors sold 5 CME Group shares in Q3 2023, an estimated $994.
CME Group made up 0.01% of Column Capital Advisors's portfolio in Q3 2023, its #243 holding.
Column Capital Advisors first reported a position in CME Group in Q4 2019 and has held it in 16 quarters since.
1,230 funds tracked by Wall St. Rank held CME Group as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.